Related Experiment Video
Updated: May 16, 2026

Rab10 Phosphorylation Detection by LRRK2 Activity Using SDS-PAGE with a Phosphate-binding Tag
Published on: December 14, 2017
Heterogenous Neuropathology in a Pedigree with RAB39B-Related Parkinson's Disease
Caitlin Latimer1,2, Oswaldo Lorenzo-Betancor1,3, Dong-Hui Chen3
1Veteran Affairs Puget Sound Health Care System, Seattle, Washington, USA.
Background:
In 2015, we reported a family with Parkinson's disease resulting from the RAB39B p.G192R (c.574G>A) variant. Since then, two affected brothers from the family have undergone autopsy.
Objectives:
To characterize neuropathological findings, assess intracellular distribution of RAB39B protein, and examine the effect of p.G192R on α-synuclein and tau.
Methods:
Detailed neuropathological assessments were performed on both siblings. Dopaminergic neurons were generated from induced pluripotent stem cells (iPSCs) from an affected and unaffected male in this kindred. Western blots were performed to measure RAB39B, α-synuclein, phospho-α-synuclein, and phospho-tau.
Results:
The younger brother had neocortical stage Lewy body disease (LBD) pathology and an unusual pattern and burden of four-repeat (4R) tau pathology that included neocortical neurofibrillary tangles, pretangles, and neurites in the absence of β-amyloid pathology. The older brother's brain showed a similar pattern of 4R tau pathology but had no LBD pathology. Robust RAB39B immunostaining was seen in p.G192R carriers and non-carriers. In p.G192R iPSC-derived neurons, RAB39B protein was reduced by ~50% and disproportionately diminished in peripheral cell processes compared with cell bodies. Aberrant forms of both α-synuclein and tau were observed in p.G192R neurons.
Conclusions:
The intrafamilial pathological heterogeneity observed here is unusual for monogenic parkinsonism and suggests that mechanisms underlying RAB39B-related neurodegeneration might be complex. Our results from iPSC-neurons provide additional support that RAB39B p.G192R promotes α-synuclein and tau co-pathology. Further work in model systems based on RAB39B p.G192R might offer important insights into the interplay between α-synuclein and tau that are applicable to multiple neurodegenerative disorders. © 2026 The Author(s). Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society. This article has been contributed to by U.S. Government employees and their work is in the public domain in the USA.
Insights
Parkinson's disease linked to RAB39B variant shows complex pathology. Induced neurons reveal RAB39B reduction, promoting alpha-synuclein and tau co-pathology, offering insights into neurodegeneration.
Area of Science:
- Neuroscience
- Genetics
- Cell Biology
Background:
- A family with Parkinson's disease (PD) was previously linked to the RAB39B p.G192R variant.
- Two affected brothers from this family underwent post-mortem neuropathological examination.
Purpose of the Study:
- To characterize the neuropathology in two brothers with RAB39B p.G192R.
- To assess the intracellular distribution of RAB39B protein.
- To investigate the impact of the p.G192R variant on alpha-synuclein and tau pathology.
Main Methods:
- Detailed neuropathological assessment of both siblings' brains.
- Generation of dopaminergic neurons from induced pluripotent stem cells (iPSCs) of affected and unaffected individuals.
- Western blot analysis to quantify RAB39B, alpha-synuclein, phospho-alpha-synuclein, and phospho-tau levels.
Main Results:
- One brother exhibited Lewy body disease (LBD) and a distinct pattern of four-repeat (4R) tau pathology without beta-amyloid.
- The other brother showed similar 4R tau pathology but lacked LBD.
- RAB39B protein was reduced by approximately 50% in p.G192R iPSC-derived neurons, with diminished presence in cell processes, and aberrant alpha-synuclein and tau forms were observed.
Conclusions:
- The observed intrafamilial heterogeneity in pathology is atypical for monogenic parkinsonism, suggesting complex RAB39B-related neurodegeneration mechanisms.
- Results from iPSC-neurons support the role of RAB39B p.G192R in promoting alpha-synuclein and tau co-pathology.
- Further research using RAB39B p.G192R models could illuminate the interplay of alpha-synuclein and tau in neurodegenerative disorders.
More Related Videos
Related Concept Videos
Parkinson Disease ll: Pathophysiology
Parkinson Disease l: Introduction
Parkinson's Disease: Overview
Pedigree Analysis
Lysosomal Hydrolases
Neural Regulation

